BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35560987)

  • 1. Effect of pulmonary artery pressure-guided therapy on heart failure readmission in a nationally representative cohort.
    Kishino Y; Kuno T; Malik AH; Lanier GM; Sims DB; Ruiz Duque E; Briasoulis A
    ESC Heart Fail; 2022 Aug; 9(4):2511-2517. PubMed ID: 35560987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
    Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
    Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
    Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
    JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.
    Adamson PB; Abraham WT; Stevenson LW; Desai AS; Lindenfeld J; Bourge RC; Bauman J
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27220593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirty-day readmissions after atrial fibrillation catheter ablation in patients with heart failure.
    Lima FV; Kennedy KF; Sheikh W; French A; Parulkar A; Sharma E; Henien S; Wu M; Chu A
    Pacing Clin Electrophysiol; 2020 Sep; 43(9):930-940. PubMed ID: 32691859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
    Martinez RA; Shnayder M; Parreco J; Gaffney L; Eby M; Cortolillo N; Lopez M; Zeltzer J
    Ann Vasc Surg; 2018 Oct; 52():96-107. PubMed ID: 29777842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Ablation for Atrial Fibrillation on Heart Failure Readmission Rates.
    Joy PS; Gopinathannair R; Olshansky B
    Am J Cardiol; 2017 Nov; 120(9):1572-1577. PubMed ID: 28886855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database.
    Martin GP; Kwok CS; Van Spall HGC; Volgman AS; Michos E; Parwani P; Alraies C; Thamman R; Kontopantelis E; Mamas M
    BMJ Open; 2019 Aug; 9(8):e029667. PubMed ID: 31444188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure: Same-hospital vs. different-hospital readmission outcomes.
    Lahewala S; Arora S; Tripathi B; Panaich S; Kumar V; Patel N; Savani S; Dave M; Varma Y; Badheka A; Deshmukh A; Gidwani U; Gopalan R; Briasoulis A
    Int J Cardiol; 2019 Mar; 278():186-191. PubMed ID: 30579719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-based differences in left ventricular assist device clinical outcomes.
    Imburgio S; Dandu S; Pannu V; Udongwo N; Johal A; Hossain M; Patel P; Sealove B; Almendral J; Heaton J
    Catheter Cardiovasc Interv; 2024 Feb; 103(2):376-381. PubMed ID: 37870108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between depression and readmission of heart failure: A national representative database study.
    Patel N; Chakraborty S; Bandyopadhyay D; Amgai B; Hajra A; Atti V; Das A; Ghosh RK; Deedwania PC; Aronow WS; Lavie CJ; Di Tullio MR; Vaduganathan M; Fonarow GC
    Prog Cardiovasc Dis; 2020; 63(5):585-590. PubMed ID: 32224112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
    Angermann CE; Assmus B; Anker SD; Asselbergs FW; Brachmann J; Brett ME; Brugts JJ; Ertl G; Ginn G; Hilker L; Koehler F; Rosenkranz S; Zhou Q; Adamson PB; Böhm M;
    Eur J Heart Fail; 2020 Oct; 22(10):1891-1901. PubMed ID: 32592227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Readmission-free period and in-hospital mortality at the time of first readmission in acute heart failure patients-NRD-based analysis of 40,000 heart failure readmissions.
    Altibi AM; Prousi G; Agarwal M; Shah M; Tripathi B; Ram P; Patel B
    Heart Fail Rev; 2021 Jan; 26(1):57-64. PubMed ID: 31897907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations.
    Tripathi B; Atti V; Kumar V; Naraparaju V; Sharma P; Arora S; Wojtaszek E; Gopalan R; Siontis KC; Gersh BJ; Deshmukh A
    J Am Heart Assoc; 2019 Oct; 8(19):e013026. PubMed ID: 31533511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs.
    Varma N; Hu Y; Connolly AT; Thibault B; Singh B; Mont L; Nabutovsky Y; Zareba W
    Heart Rhythm; 2021 Sep; 18(9):1577-1585. PubMed ID: 33965608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.
    Abraham J; Bharmi R; Jonsson O; Oliveira GH; Artis A; Valika A; Capodilupo R; Adamson PB; Roberts G; Dalal N; Desai AS; Benza RL
    JAMA Cardiol; 2019 Jun; 4(6):556-563. PubMed ID: 31090869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.